Financhill
Back

Structure Therapeutics Vs. Amgen Industry Stock Comparison

Sell
36

GPCR
Structure Therapeutics

Last Price:
39.29
Seasonality Move:
-35.87%
Sell
42

AMGN
Amgen

Last Price:
319.23
Seasonality Move:
10.36%
Sell
36
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $39.30. The Score for GPCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Amgen (AMGN) is a Sell

Is Amgen a Buy, Sell or Hold?

  • The current Amgen [AMGN] share price is $319.29. The Score for AMGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • AMGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $39.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight selling pressure.

AMGN Stock Price Chart

What is Amgen's stock price today?

  • The Amgen share price today is $319.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 49.78 Sell
Chaikin Money Flow: -61027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.61 - 41.39) Sell
Bollinger Bands (100): (36.19 - 42.83) Sell

AMGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.63 Sell
Relative Strength Index (14 RSI): 48.67 Sell
Chaikin Money Flow: 1357084 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (316.23 - 322.63) Sell
Bollinger Bands (100): (314.43 - 332.01) Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.15 Buy
20-day SMA: 38.81 Buy
50-day SMA: 39.59 Sell
200-day SMA: 40.27 Sell
8-day EMA: 39.42 Sell
20-day EMA: 39.31 Sell
50-day EMA: 39.42 Sell
200-day EMA: 39.72 Sell

AMGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 317.71 Buy
20-day SMA: 319.55 Sell
50-day SMA: 324.1 Sell
200-day SMA: 306.62 Buy
8-day EMA: 318.23 Buy
20-day EMA: 319.38 Sell
50-day EMA: 321.57 Sell
200-day EMA: 307.79 Buy

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.

Amgen Earnings Growth & AMGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $1.07 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amgen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):